Earlier this week, Metallica announced that they had to postpone their upcoming performance in Denmark due to singer James Hettfield‘s illness, which affects his throat. This news brought questions regarding their performance at The Grammys on Sunday night. However, just in case Hettfield isn’t back to 100%, they’ve recruited some help for their vocal duties–recent Super Bowl LI Halftime Show star Lady Gaga While Metallica and Lady Gaga sound like a strange pairing, the choice makes more sense than you may think. Some of Gaga’s earliest singing gigs were with a Led Zeppelin tribute band (when she still went by her given name, Stefani Germanotta). Gaga recently got the Led out on Howard Stern, impressively howling a few lines from “Black Dog” and speaking about how to train your voice to withstand the wear of such vocal parts. If her searing wail in the video below is any indication, Lady Gaga will fit right in with Metallica for the televised performance.You can catch Metallica with Lady Gaga, as well as a slew of other star-studded collaborations (like Daft Punk with The Weeknd and A Tribe Called Quest with Anderson .Paak) on Sunday night at 8pm Eastern on CBS.[h/t – Consequence of Sound]
P.S. Run and tell this! Hairspray Live!’s Ephraim Sykes captured the adorable Shahadi Wright Joseph throwing down a rap snippet from “Satisfied.” Watch the pint-sized Schuyler Sister below and be sure to catch the two playing siblings in the NBC broadcast on December 7. Jesus Christ Superstar Makes a Divine ReturnFresh off of winning the Evening Standard Award for Best Musical, it has been announced that the Regent’s Park Open Air Theatre production of Jesus Christ Superstar will make a comeback. The Andrew Lloyd Webber musical will return to the outdoor venue from August 11, 2017 through September 16.Lee Mack to Make West End Debut in The Miser Comedian Lee Mack has joined the previously announced Griff Rhys Jones in Molière’s classic comedy The Miser. Newly adapted by Sean Foley and Phil Porter, the West End production is set to start previews on March 1, 2017, officially opening on March 13 at London’s Garrick Theatre. The limited engagement will end on June 10.Golnesa “G.G.” Gharachedaghi Joins Sex TipsAnother Bravo star is headed to the lucky 777 Theatre! Shahs of Sunset’s Golnesa “G.G.” Gharachedaghi (a.k.a. The Persian Princess) will make her stage debut as Robyn in Sex Tips for Straight Women from a Gay Man from December 3 through December 10. During her time in the production, a portion of the play’s proceeds will benefit her charity Little Warriors, which supports children suffering from a variety of autoimmune diseases.Broadway Isn’t Ready to Make NiceWe know how the Broadway community feels about the results of the presidential election. Last week, a group of powerful young women in the theater community, including A Bronx Tale star (and Broadway.com vlogger) Ariana DeBose, The Color Purple’s Patrice Covington and Spring Awakening alum Kathryn Gallagher, gathered together to raise their voices in song in Central Park. Along with Broadway alums Ashley Park, XiaoChuan Xie, Elisabeth Evans and UptownWorks NYC co-creator Mandie Black, the group performed The Dixie Chicks’ “Not Ready to Make Nice.” Take a look at the video below, which was shot by Broadway.com’s Photo Director Caitlin McNaney and Social Media Manager Caitlyn Gallip. Santino Fontana in ‘Crazy Ex-Girlfriend’ Here’s a quick roundup of stories you may have missed today. Spoiler Alert: Santino Fontana Exits Crazy Ex-GirlfriendWe don’t want to settle for this! Tony nominee and Broadway.com Audience Choice Award winner Santino Fontana has departed the CW’s instant cult fave Crazy Ex-Girlfriend. In the most recent season two episode, his character Greg finally headed off to school to take care of himself and his alcohol addiction. We can’t wait to see what Fontana’s got in store for us next (we’re hoping a guest visit to West Covina now and then). Try not to tear up watching his swan song below, and catch the hilarious show on Fridays at 9PM/8PM Central on The CW. View Comments
By Geraldine Cook/Diálogo February 01, 2017 El Salvador has intensified its fight against the country’s criminal organizations, especially gangs. New government regulations and the participation of the Armed Forces are part of the strategies to eliminate the illegal structures of criminal organizations.Mara Salvatrucha and Barrio 18 are two of the main Salvadoran gangs involved in, among other criminal acts, drug trafficking, arms smuggling, human trafficking, extortion, and kidnapping. According to a report from the Central Reserve Bank of El Salvador published in April 2016, the violence generated by gangs cost the nation $4 million.The financial cost and national and regional security concerns caused by gangs worry Colonel Salvador Ernesto Hernández Vega, general Chief of Staff of the Salvadoran Air Force. That is why since assuming office in December 2015, he has supported his country’s Armed Forces role in helping to keep the peace internally and to defend the sovereignty and integrity of domestic airspace. Combating gangs in his country and throughout Central America has become one of his fundamental priorities.Col. Hernández spoke with Diálogo during the Central American Air Chiefs Conference, held December 12 and 13, 2016 at the Davis-Monthan Air Base in Tucson, Arizona.Diálogo: What is the importance of El Salvador’s presence at the Central American Air Chiefs Conference?Colonel Ernesto Hernández Vega: Participation is important to me because one can meet and interact with leaders from the region’s air forces. I think that it’s quite important. If we are seeking integration in the region and collaboration amongst ourselves, then what could be better than meeting each other and being able to exchange ideas and experiences and, why not, needs and problems? All of this enriches the region and gives us tools to be able to interact and face problems or solutions jointly.Diálogo: What is El Salvador’s goal for its participation in this conference?Col. Hernández: We want to collaborate to prevent transnational crimes like smuggling and the illicit trafficking of drugs through the Central American region. One of our objectives is this: for them to stop using our maritime, land, or air territory for this type of illicit activity. Likewise, it is a good opportunity for us to exchange ideas, propose solutions, or listen to solutions that could benefit the region and El Salvador itself.Diálogo: Which are the most important security issues facing El Salvador?Col. Hernández: Currently, the main issue facing El Salvador is gangs. We have a high daily death rate resulting from this blight, followed by drug trafficking, but I don’t think trafficking affects El Salvador as much as consumption does. Our main problem is gangs, which also affect the country’s economy, stability, and security.Diálogo: What agreements/collaboration programs does your country have with the United States and other partner nations in the region to face these kinds of issues?Col. Hernández: Coming here and being able to interact with various participants in the region demonstrates our collaboration with these countries. El Salvador has collaborative programs with Air Forces Southern and U.S. Southern Command. We’ve also had the opportunity to exchange ideas, recommendations, and solutions with the New Hampshire National Guard, which is our partner state [in the State Partnership Program]. Additionally, this meeting involves several members of the System of Cooperation among the American Air Forces (SICOFAA, per its Spanish acronym), which is an excellent program aimed at regional integration, trust-building, cooperation, and finding solutions to regional problems. It is a regional program that is very beneficial and also gives us the opportunity to interact with leaders from the air forces of Central America. In El Salvador and the Dominican Republic, we have the Central American Armed Forces Conference (CFAC, per its Spanish acronym), which is another beneficial tool, another program to face all the current challenges for the regional armed forces and, specifically, the air forces.As countries from the Central American region, I think that, like many other air forces, we have many weaknesses, such as the scarcity of resources, and I am convinced that we can only face and create solutions to these regional problems by integrating as a region.Diálogo: In terms of SICOFAA, as a member country, what do you think is the importance of this type of integrated cooperation system?Col. Hernández: SICOFAA is quite important because it allows the air forces to know each other better, to have more trust and greater cooperation among air forces. SICOFAA facilitates cooperation, consulting, and the resolution of problems through the kinds of close relationships that we have forged as members.Diálogo: As head of the Salvadoran Air Force, what is your biggest challenge?Col. Hernández: Our fundamental challenge, just like any other air force in the region or the world, is resources. Maintaining and developing an air force anywhere, regardless of what air assets you have, is expensive. So one of the challenges is maintaining an air force that is versatile, competent, useful to the region, and also has personnel that is suitable and appropriately trained to face the challenges that every air force has.Diálogo: Colonel Hernández, would you like to add anything else for readers in the region?Col. Hernández: First, I would like to thank Air Forces Southern for this invitation, and, second, I would like to invite all the air force members who attended [the Central American Air Chiefs Conference] to join forces with each other because integration is the only tool that will give us answers to the needs and issues we have as the Central American region.
Oct 17, 2006 (CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.The vaccine induced an immune response not only against the targeted H5N1 strain, but against other strains as well, according to Baxter. The company announced results of the phase I/II trial Oct 4 but had not released study data until Oct 11, at the World Vaccine Congress in Lyon, France.”This is the first clinical demonstration that a candidate H5N1 vaccine can induce antibodies that neutralize widely divergent strains of H5N1,” said Hartmut Ehrlich, MD, vice president for global research and development, in an Oct 4 Baxter news release. He added that the data “suggest that the vaccine may provide wider protection for a larger number of people before and during a pandemic.”The vaccine was produced using Baxter’s vero cell–based technology and dead whole viruses of wild-type H5N1 avian influenza strain A/Vietnam/1203/2004.Cell-based vaccines are grown in mammalian cells (often from kidneys) instead of chicken eggs and in theory could help meet “surge capacity” needs because the cells can be frozen for stockpiling. The method also can shave about a month off the production time for flu vaccines, which is normally about 6 months. But cell-based flu vaccines face practical hurdles, as discussed below.The cell-based vaccine was administered to 270 healthy adults aged 18 to 45 in Austria and Singapore. Groups of 44 to 48 volunteers received either 3.75, 7.5, 15, or 30 micrograms (mcg) of the vaccine with an aluminum oxide adjuvant, a substance that stimulates immune response. Two other groups of 45 each received 7.5 or 15 mcg of vaccine without an adjuvant. All volunteers were vaccinated on the first day of the trial and again 21 days later.Three weeks after the second injection, testing of serum samples showed that 15 of 23 (65%) volunteers in the 3.75-mcg group had a strong antibody response to the vaccine virus (microneutralization titer 1:20 or higher). In comparison, 15 in 20 (75%) of the adjuvanted 7.5-mcg group and 22 of 27 (82%) of the nonadjuvanted 7.5-mcg group showed a strong antibody response.The vaccine also showed evidence of cross-protection against other H5N1 strains. Microneutralization testing for antibody response to a 1997 Hong Kong strain showed a 71% (12 of 17) rate of response in the 3.75-mcg group, compared with an 81% (13 of 16) and a 96% (21 of 22) response in the adjuvanted and nonadjuvanted 7.5-mcg groups, respectively.For a 2005 H5N1 strain from Indonesia, the rates of antibody response were 35% (6 of 17), 63% (10 of 16), and 68% (15 of 22), respectively.Commenting on the diverse makeup of these nontargeted H5N1 viruses, Ehrlich told CIDRAP News via e-mail, “They are strains that are substantially different from Vietnam 1203. One is the same clade [family] but emerged 7 years earlier; the other one is a different clade. [This is] in contrast to many other strains—for example, Vietnam 1194—which are very similar to Vietnam 1203 and are expected to therefore induce cross-neutralization . . . and were indeed protective in our animal studies.”Ehrlich, who presented the data in Lyon, said the serum samples from the volunteers who received 15 or 30 mcg of the vaccine had not yet been analyzed. Final results of the study will be available by the end of the year, according to the Baxter news release.The rate of adverse events, released this week, demonstrated the apparent safety of the vaccine. After two injections, 3% of patients (6 of 201) had fever, 6.0% (12 of 201) experienced malaise, and 3.5% (7 of 201) reported shivering, the company said.Commenting on the implications of the findings, infectious-disease expert Michael T. Osterholm, PhD, MPH, said Baxter’s vaccine—like other H5N1 vaccines in development—is a long way from offering an early solution to the threat of a flu pandemic. Osterholm is director of the University of Minnesota Center for Infectious Disease Research and Policy, publisher of the CIDRAP Web site.Aside from the problem that it will take months to develop a specific vaccine once a pandemic strain of flu emerges, the Food and Drug Administration has not yet approved any cell-culture flu vaccine, Osterholm told CIDRAP News. “In fact, they’re a long ways from licensure,” he said.In addition, efforts to use a vaccine during a pandemic will encounter a host of practical problems, he added. “We have to think of the whole supply chain. What about syringes? Will they be available when a pandemic hits? What about a whole host of supplies that we’ll need during a pandemic that won’t be available because of our just-in-time infrastructure?”These practical considerations are so crucial that, if all these new vaccines were released today, none of them would make the world a safer place.”Baxter said it plans to begin phase III trials of the vaccine early next year.Baxter is collaborating with DynPort Vaccine Corp. to develop cell-based vaccines. In May, the US Department of Health and Human Services awarded DynPort a $41 million contract for cell-based flu vaccine work. The funds came from $3.3 billion that Congress appropriated for pandemic preparedness last December.See also:Baxter news releasehttp://www.rxpharmacy.md/news/baxter_announces_safety_and_immunogenicity_results_from_phase_i_ii_clinical_trial_of_cell_based_candidate_h5n1_pandemic_vaccine.htmlMay 4 CIDRAP News story “US awards $1 billion for cell-based flu vaccines”Jun 27, 2005, CIDRAP News story “Momentum builds for cell-culture flu vaccines”
May 26, 2009 (CIDRAP News) –Two vaccine companies, Sanofi Pasteur and GlaxoSmithKline, recently announced they received their first orders from the US government for a vaccine and adjuvant to protect the country against the novel H1N1 virus.Sanofi, in a statement released yesterday, said the initial order it received from the Department of Health and Human Services (HHS) covers the production of bulk vaccine and related activities and is worth $190 million. On May 22, Glaxo said in a press release that HHS ordered vaccine antigen and the company’s proprietary adjuvant system, AS03. Adjuvants are compounds that enhance a vaccine’s immune response, offering the possibility of stretching antigen supplies.The announcements from the two companies follow a May 22 announcement from HHS that secretary Kathleen Sebelius was directing about $1 billion in existing funds toward clinical studies and commercial production of bulk vaccine antigen and adjuvant.Federal officials have announced plans to support the development of a novel H1N1 vaccine, but have taken pains to explain that the decision to use it would be made separately.The Centers for Disease Control and Prevention (CDC) has said it hopes to wrap up work on a seed strain to send to vaccine makers within the next few weeks. Once companies receive the seed strain, they can develop pilot lots to begin safety, efficacy, and dosage testing.The federal government’s placement of the orders falls under existing contracts that the Biomedical Advanced Research and Development Authority (BARDA) established with the companies in 2004 as part of the nation’s pandemic influenza strategy.Sanofi said it hopes to begin work on a pilot lot in June after the US Food and Drug Administration approves its working seed. The company said clinical trials could begin as early as August, but a timeline for final formulation, filling, and distribution has not been set.Wayne Pisano, Sanofi’s president and chief executive officer, said in the press release that though a number of complex steps need to be taken before a vaccine is available, the company’s experience in developing the prepandemic H5N1 avian influenza vaccine will be helpful. “We look forward to further demonstrating our experience and expertise in vaccine development as we prepare for this new threat from AH1N1,” he said.Production of the new H1N1vaccine for HHS will take place at the company’s recently licensed new production facility in Swiftwater, Pa. As soon as the company finishes production of seasonal influenza vaccine at its second Swiftwater facility, it can produce the novel H1N1 vaccine at both plants. The two plants, when operating at full capacity, can make about 150 million doses of seasonal flu vaccine.Meanwhile, Glaxo said it expects to fill HHS’ adjuvant order within the next few months and hopes to produce the first antigen doses 4 to 6 months after receiving the novel H1N1seed strain. The company said its proprietary adjuvant, already approved as a component of the H5N1 vaccine in Europe and some Asian countries, is the subject of 15 additional clinical trials, including one involving a seasonal flu vaccine.Both Sanofi and Glaxo said they are in ongoing discussions with other countries about producing novel flu vaccine for national stockpiles.See also:May 25 Sanofipress releaseMay 22 Glaxopress releaseMay 22 HHS press releaseMay 6 CIDRAP News story “FDA approves new vaccine facility”
EnBW has installed 44 of the 87 Siemens Gamesa wind turbines on the Hohe See and Albatros offshore wind farms in the German North Sea.Fred. Olsen Windcarrier’s installation vessels Brave Tern and Blue Tern load the components for four wind turbines at a time at the port of Esbjerg in Denmark and attach them offshore to foundations already installed in the seabed.The first turbine was installed at the site some 95 kilometres north of Borkum and 100 kilometres northwest of Helgoland in early April.The total of 87 Siemens Gamesa 7MW wind turbines with 609MW of installed output are due to be connected to the grid by the end of 2019.The project is being coordinated by the offshore branch of EnBW in Hamburg. The Canadian energy infrastructure company Enbridge Inc. holds 49.9 percent of the shares in the 71-turbine Hohe See and the neighbouring 16-turbine Albatros. EnBW has retained the remaining 50.1 percent in both projects.Photos: Fred. Olsen Windcarrier AS/Tony Cato
Promoted ContentThe Very Last Bitcoin Will Be Mined Around 2140. Read MoreBest & Worst Celebrity Endorsed Games Ever MadeWho Earns More Than Ronaldo?Top 10 Most Romantic Nations In The World6 Ridiculous Health Myths That Are Actually True13 kids at weddings who just don’t give a hootPlaying Games For Hours Can Do This To Your Body8 Best 1980s High Tech Gadgets6 Extreme Facts About HurricanesEver Thought Of Sleeping Next To Celebs? This Guy Will Show YouWho Is The Most Powerful Woman On Earth?Nothing Compares To Stargazing Places Around The World But he said the government had faced a difficult situation with limited capacity to conduct a quarantine onshore and pressure not to put those on board through a second isolation period.“Doing more than 14 days of quarantine… might have been the way to go,” he said.“But I also have to say that this process… must have been quite difficult,” he noted.Read Also: Virus hits Super Rugby as Japan match in doubtHe cautioned there was no evidence yet that passengers had infected others after leaving the boat.“We have to see what happens in the next coming one to two weeks… if the secondary infections from the passengers of the cruise happen, we have to really think about it,” he said.“These kind of ways may have not been perfect.”FacebookTwitterWhatsAppEmail分享 “We are now on the crossroads for the containment of the COVID-19… within our country,” said Ohmagari, director of the department of infectious diseases at Japan’s National Center for Global Health and Medicine. Japan has confirmed at least 186 domestic infections, including three deaths since the outbreak began, and the government has come under pressure for a relatively hands-off approach. But Ohmagari, who helps advise the government, defended measures, including requesting – but not ordering – the cancellation of major events, and encouraging teleworking and off-peak commuting.“If we keep going with what we are doing right now we do have (the) significant possibility for the containment or the elimination of this COVID-19,” he said.He conceded however there is still significant uncertainty, which has cast a shadow as Tokyo gears up to host the Olympics from July.Ohmagari said he would want to see domestic transmissions of the virus brought under control before the Games.“We have to see the situation at least three weeks from now,” he said.“If we can contain the secondary transmission within the country… I think that’s a very good sign, and it’s a very good signal for us to decide ‘go’ for the Olympics and Paralympics.”But if infections are continuing domestically, authorities will face a “big, big decision”.“If there is a significant outbreak or… a pandemic of this kind of infectious disease, we really have to think about holding this kind of large event, is it feasible or not?”– Boat quarantine was ‘not perfect’ –The government’s handling of the crisis has come under scrutiny internationally and domestically, with opposition lawmakers questioning the relatively low number of tests administered in Japan, compared to 57,000 in South Korea.The outbreak of COVID-19 has cast a shadow over preparations for the Tokyo 2020 Olympics which open in July Loading… Japan is at a “crossroads” in its bid to prevent a major coronavirus outbreak and may need to reconsider the Olympics if domestic transmissions are not brought under control, an expert advising the government has warned. Japan faced significant criticism for its handling of a cruise ship placed in quarantine after a former passenger contracted the virus Norio Ohmagari, an infectious disease specialist, told AFP in an interview he believes measures being taken by the government can still prevent the virus from spreading more widely, but that the next three weeks will be critical.Advertisement Ohmagari acknowledged that “limiting the number of tests makes grasping the true number of cases impossible,” but said the tests could not always detect infections.“Catching all the people who are having this virus is impossible” he said. “We can see the trend.”Japan has also faced significant criticism for its handling of a cruise ship placed in quarantine after a former passenger contracted the virus.More than 700 people who were on board the Diamond Princess have so far tested positive for the virus, with multiple new cases emerging while the ship was in quarantine and even among passengers allowed off the boat after initially testing negative.“The process with the quarantine has not been perfect,” Ohmagari said.“I think that is a fact, we are now seeing it.”Japan’s government has urged the cancellation, delay or downsizing of major events in coming weeks to limit the spread of the virus Japan may need to reconsider holding the Olympics if it cannot bring domestic transmissions of the new coronavirus under control, an expert has warned
Barcelona’s vice president Jordi Cardoner has told ESPN that his club, along with most other clubs in Europe, will likely be trading rather than buying players this summer. Speaking frankly in an interview quoted by Simon Kuper, the Barca administrator admitted that the club had already lost between €120m and €140m in lost revenue due to the ongoing hiatus. He also asserted that the transfer market was going to be very different this year – and perhaps for a lot longer: “[Player exchanges] will be part of the game. This is the way things will happen for next season for European clubs,” the Spaniard explained.Advertisement Promoted Content15 Extremely Surprising Facts About Disney Princesses10 Irresistibly Gorgeous Asian Actresses10 Extremely Dirty Seas In The WorldThe Very Last Bitcoin Will Be Mined Around 2140. Read More5 Of The World’s Most Unique Theme ParksBest & Worst Celebrity Endorsed Games Ever Made9 Heroes Of Popular Memes Then And NowA Guy Turns Gray Walls And Simple Bricks Into Works Of ArtThe 90s Was A Fantastic Decade For Fans Of Action MoviesWhich Country Is The Most Romantic In The World?6 Most Overpowered Live Action Disney CharactersContemplate Life At These 10 Stargazing Locations Loading… That seems likely, but even then only top teams like Barcelona have the depth and the quality players in their squad to allow them to pull off these kinds of deals. Barcelona vice president Jordi Cardoner Read Also: Setien: Messi, Barcelona will always be together It’s hard to imagine teams lower down the pyramid being able to engage even in simple loan trades. The fact that Barcelona have a stable of young players, like other top clubs, means they have a much stronger hand to work with. The executive also suggested three party deals could become more common as teams desperately look for solutions in a truncated transfer period. FacebookTwitterWhatsAppEmail分享
“Then I visited the city of Naples, saw the environment with my own eyes and realised that I am in a wonderful city. “(Racism) is a worldwide issue. I’m sure I have chosen well and the Neapolitans will make me feel at home with their love.” Racism has been a recurring problem in Italian stadiums, including monkey noises directed at black players.Last season Brescia’s Italy international Mario Balotelli threatened to walk off the pitch after being targeted at Lazio and Hellas Verona.But Osimhem said he had “always been convinced that Naples was the best choice for me both for the present and for the future.“Both as a man and as a footballer.”Napoli’s Senegalese international defender Kalidou Koulibaly confessed Osimhen had asked him about racism in Italy before joining the club.“He called me, we talked about racism, I told him that coming to Naples he won’t have these problems, he will choose the right city,” Koulibaly told La Gazzetta dello Sport.“I too felt the bitterness of the racist insult, but never in Naples. I reassured him, I told him that if he comes, he will have made the best choice.”Interestingly, Osimhen was one of the most expensive players in Serie A history, costing almost double Napoli’s previous club record of around 40 million euros paid for Gonzalo Higuain in 2013 and Hirving Lozano last year.“Playing with Napoli is a dream,” he said.“I thank (owner Aurelio) De Laurentiis and (coach Gennaro) Gattuso who immediately considered me as their son.“I decided to accept the challenge with Napoli right after speaking with them. Loading… Read Also: Messi speaks out amid Barcelona exit talks“For a young player like me, having this warmth is essential.”Napoli finished seventh in Serie A last season and qualified for the Europa League after winning the Italian Cup, their first trophy in six years.The new Serie A season kicks off on September 19.FacebookTwitterWhatsAppEmail分享 Super Eagles forward and Napoli new signing Victor Osimhen admitted on Wednesday he was skeptical of joining the Serie A club because of the racist reputation of some fans in Italy. Napoli splashed out a club record fee of up to 80 million euros ($94.6 million) to sign the Nigeria international from French outfit Lille. “There was a bit of scepticism on my part, because the issue of racism is a problem that exists everywhere,” Osimhen told journalists.Advertisement Promoted Content10 Phones That Can Easily Fit In The Smallest Pocket8 Superfoods For Growing Hair Back And Stimulating Its GrowthA Guy Turns Gray Walls And Simple Bricks Into Works Of Art5 Of The World’s Most Unique Theme ParksThe 10 Most Irresistible Asian Actresses7 Black Hole Facts That Will Change Your View Of The Universe10 Phones That Can Work For Weeks Without RechargingCan Playing Too Many Video Games Hurt Your Body?Some Impressive And Almost Shocking Robots That ExistWho Earns More Than Ronaldo?Which Country Is The Most Romantic In The World?5 Of The World’s Most Unique Theme Parks
Southampton created the first decent opening when a low centre from Schneiderlin was beaten away by Norwich keeper Mark Bunn, who then tipped over Lallana’s rising 20-yard drive. Norwich were struggling to get hold of the ball in midfield and when right-back Russell Martin did get forward and float in a teasing ball through the penalty area, goalkeeper Boruc got there ahead of Kei Kamara, making his first start since a loan move from Kansas City. Southampton broke quickly on 28 minutes through Rickie Lambert and his onward pass found Gaston Ramirez in space at the edge of the Norwich penalty area, but his attempted chip was palmed out by Bunn as Javier Garrido mopped up the loose ball. Jay Rodriguez burst down the left early in the second half and cut into the penalty area and his cross was cleared by Sebastien Bassong, but the ball fell to Lallana some 12 yards out. However, with the goal at his mercy, the Southampton skipper could only blaze the ball high into the Barclay End. The pace of the match intensified as Japan defender Yoshida produced a superb block to prevent Holt getting on the end of Snodgrass’ cross after a great knockdown by Kamara. At the other end, Snodgrass was played in by Hoolahan, but the ball ran away from the Scotland international as he went around the goalkeeper, which allowed Yoshida to hack clear. There was late drama as Shaw’s nudge on Holt saw Clattenburg give a penalty but Boruc guessed right and earned Southampton a draw. Norwich captain Grant Holt saw his stoppage-time penalty saved as Southampton battled to a goalless draw in atrocious conditions at Carrow Road. Press Association With heavy rain before kick-off being followed by sleet, chances were few and far between. Saints skipper Adam Lallana blasted over when in front of an open goal, while Japan defender Maya Yoshida made vital blocks to prevent Holt and Robert Snodgrass scoring. There was late drama, though, as Luke Shaw was ruled to have pushed over Holt just inside the penalty area, as referee Mark Clattenburg pointed to the spot after consulting with his assistant. Southampton, though, felt justice was served as Artur Boruc produced a decent stop down to his left to secure a point for the visitors.